Non-invasive Test Effective for Colorectal Cancer Screening
(05/12/2008)
A new, non-invasive colorectal cancer screening test from Exact Science is now available and supported by the American Cancer Society and other major medical groups. Study results showing the test’s efficacy have been reported in the April 2008 supplement of Gastroenterology.
Colon Cancer Outcomes Differ Between Men and Women
(05/09/2008)
Variations within the gene responsible for epidermal growth factor receptors (EGFR) may be predictive of differing outcomes between male and female patients diagnosed with metastatic colon cancer. Details of the study have recently been published in the Journal of Cancer Research.
Changes in Lifestyle May Improve Quality of Life for Colon Cancer Survivors
(05/07/2008)
A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among colon cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
Physicians with More Training Perform More Effective Colonoscopies
(05/07/2008)
A recent trial conducted at 15 different medical centers in Korea indicates that a physician must perform at least 150 colonoscopies to be considered competent at the procedure. Details of the study were recently published in the journal Gastrointestinal Endoscopy.
Celebrex® Reduces Colon Adenomas
(04/17/2008)
The COX2-inhibitor Celebrex® (celecoxib) reduces the rate of colon adenomas at five years and appears safe, even among patients with cardiovascular disease. These results were recently presented as a late-breaking abstract at the 2008 annual meeting of the American Association for Cancer Research.
More...
Screening/Prevention
Non-invasive Test Effective for Colorectal Cancer Screening
(05/12/2008)
A new, non-invasive colorectal cancer screening test from Exact Science is now available and supported by the American Cancer Society and other major medical groups. Study results showing the test’s efficacy have been reported in the April 2008 supplement of Gastroenterology.
Physicians with More Training Perform More Effective Colonoscopies
(05/07/2008)
A recent trial conducted at 15 different medical centers in Korea indicates that a physician must perform at least 150 colonoscopies to be considered competent at the procedure. Details of the study were recently published in the journal Gastrointestinal Endoscopy.
Celebrex® Reduces Colon Adenomas
(04/17/2008)
The COX2-inhibitor Celebrex® (celecoxib) reduces the rate of colon adenomas at five years and appears safe, even among patients with cardiovascular disease. These results were recently presented as a late-breaking abstract at the 2008 annual meeting of the American Association for Cancer Research.
Drug Combination Decreases Recurrence Rate of Colon Polyps
(04/15/2008)
The combination of the difluoromethylornithine (DFMO) and sulindac reduces the rate of colon adenomas (growths or polyps) by up to 95% among patients who have had prior colon polyps. These results were presented as a late-breaking abstract at the 2008 annual meeting of the American Association for Cancer Research.
Fluctuation in Weight May Influence Risk for Colon Cancer
(04/07/2008)
A large study conducted in Austria reveals that large weight gains or losses may influence an individual’s risk for developing certain types of cancer, including colon cancer. Complete details of the study were published in the Annals of Oncology.
More...
Adjuvant (I-III, A-C)
Changes in Lifestyle May Improve Quality of Life for Colon Cancer Survivors
(05/07/2008)
A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among colon cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
March Is National Colon Cancer Awareness Month
(04/03/2008)
As the month of March brings colon cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated colorectal cancer information throughout the year.
Chemotherapy for Stage II Colorectal Cancer Improves Survival
(01/16/2008)
According to results recently published in Lancet Oncology, chemotherapy for Stage II colorectal cancer appears to provide a modest improvement in survival
Number of Lymph Nodes Removed May Not Affect Outcomes in Colon Cancer
(11/15/2007)
According to an article recently published in the Journal of the American Medical Association, the number of nodes removed during surgery for colorectal cancer does not seem to affect outcomes.
Patient Communication and Expectations: ASCO GI 2007
(10/15/2007)
The 2007 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium brought together leading experts to present and discuss new research on prevention, screening, and treatment. Dr. Neil Love and colleagues presented an abstract titled, “How well do we communicate with our patients? A survey of patients who received adjuvant chemotherapy for colorectal cancer.”
More...
Stage IV (D)/Relapsed
Colon Cancer Outcomes Differ Between Men and Women
(05/09/2008)
Variations within the gene responsible for epidermal growth factor receptors (EGFR) may be predictive of differing outcomes between male and female patients diagnosed with metastatic colon cancer. Details of the study have recently been published in the Journal of Cancer Research.
Changes in Lifestyle May Improve Quality of Life for Colon Cancer Survivors
(05/07/2008)
A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among colon cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
Combination of Erbitux® and Camptosar® Improves Outcome in Metastatic Colorectal Cancer
(04/14/2008)
The combination of Erbitux® (cetuximab) and Camptosar® (irinotecan) may be more effective than Camptosar alone for the treatment of metastatic colorectal cancer that is positive for the epidermal growth factor receptor. This study was recently published online in the Journal of Clinical Oncology.
Testing for Specific Protein May Identify Colorectal Patients Who Will Benefit from Erbitux®
(04/07/2008)
Researchers have identified a test to predict which patients with colorectal cancer would likely respond to treatment with Erbitux® (cetuximab). Details of the study were recently published in the Annals of Oncology.
Second Surgery to Remove Cancer Spread to Liver May Improve Colorectal Cancer Survival
(01/11/2008)
According to results recently published in the Archives of Surgery, a second surgery to remove colorectal cancer that has spread to the liver can significantly improve survival
More...